About Us

Who We Are

Oncostrata is a clinical science and data management consultancy in oncology and hematology. We provide dedicated support to new and established biotechs and pharma, tailoring our services to the clinical development program needs of each client.

From intelligent study start up and medical data review, ensuring data quality and integrity from the trial beginning, to key clinical documentation for health authority submissions and filing, we can help your study have the best chance for success.

Our PhD- and MD-level scientists bring expertise spanning a variety of mechanisms of action including small molecule inhibitors, immunotherapies, and cell-based therapies. We have decades of experience working on cancer clinical trials for clients across the pharmaceutical and biotech industry, clinical research networks, and academia.

Our Team

Joanna Hanks, MSc, PhD
Founder and Head of Clinical Science

  • Oncology (lung, colorectal, prostate) Small molecules, immuno-oncology

Twenty years working on oncology sponsor and investigator-initiated studies for Pharma and Biotech. Joanna has come to understand the significant challenges faced by Clinical Leads seeking scientific support for their studies. She founded Oncostrata with a mission to grow a permanent team of global clinical development experts, leveraging their expertise to provide exemplary scientific support to Sponsors at key stages in their trials.

At NIHR, Joanna collaborated with site investigators, recruiting patients, managing biomarkers and collecting data for several oncology trials, which led her to pursue a PhD comprising two large academic studies investigating DNA methylation and uracil misincorporation in colorectal cancer - this formed her PhD thesis and post doc which prepared her for the scientific rigor of clinical development.

Ana Metelo, MSc, PhD
Director, Clinical Science

  • Hematology (lymphoma, multiple myeloma, leukemia)
    Oncology (CNS tumors, Renal Cell Carcinoma)
    Small molecules, immuno-oncology, CAR T cell therapies

Dildar Hassan, BDS, MSc
Clinical Scientist & Data Manager

  • Oncology (lung, colorectal, prostate, gastric cancer)
    Hematology (leukemia)
    Small molecule inhibitors, immune modulating antibodies, proteosome inhibitors

Chinnu Kurian, PharmD
Medical Data Reviewer

  • Oncology (lung, breast)
    Hematology (leukemia, lymphoma, multiple myeloma)
    Bispecific T cell engagers, immuno-oncology

Snehal Shet, BAMS, PGDACR
Safety Scientist

  • Oncology (lung, colorectal, melanoma)
    Hematology (leukemia, lymphoma)
    Bispecific T cell engagers, small molecule inhibitors, biologic therapies

Jennifer Martin, MSc, DPhil
Clinical Scientist

  • Oncology (pediatric, lung)
    Small molecule targeted therapies, immuno-oncology

Chimi Handique, MBBS, MD
Clinical Scientist

  • Oncology (lung)
    Hematology (leukemia)
    Bispecific T cell engagers, small molecule inhibitors

Mafalda Dias, MSc, PhD
Clinical Scientist

  • Oncology (lung, breast, melanoma, osteosarcoma)
    Oncolytic virus, multi-specific antibodies, vaccines, CAR T therapies
    Preclinical and drug development

Our oncology experience is evident in everything we do.

Biotech Services
Pharma Services

Clients Who Trust Us